NEW YORK (GenomeWeb News) – Geospiza announced today a co-marketing deal with NuGen Technologies for the development of a next-generation sequencing workflow to accelerate discoveries for large disease research studies.
Financial and other terms of the deal were not disclosed.
Based in Seattle, Geospiza develops software for genetic analysis. NuGen, based in San Carlos, Calif., develops amplification and labeling systems for genomic research.
A spokeswoman for NuGen told GenomeWeb Daily News that the company will be providing library sample preparation technology to the collaboration.
"Combining our GeneSifter preconfigured lab and analysis cloud software with NuGen's Ovation and Encore reagents enables researchers to follow and document a step-by-step best practice for sample preparation combined with fully integrated data analysis and other sample information in one system," Rob Arnold, president of Geospiza, said in a statement.